A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome

Clinical trial NCT01736423 · COMPLETED

Trial details

NCT number: NCT01736423
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diarrhea-predominant Irritable Bowel Syndrome

Start date: 2012-09-01
Primary completion: 2014-05-01
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.